COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 2640: Articles 26391-26400  | Next

Evidence of significant natural selection in the evolution of SARS-CoV-2 in bats, not humans
MacLean, O. A., Lytras, S., Singer, J. B., Weaver, S., Kosakovsky Pond, S. L., Robertson, D. L.
10.1101/2020.05.28.122366 — Posted: 2020-05-29
SARS-CoV-2 transmission chains from genetic data: a Danish case study
Bluhm, A., Christandl, M., Gesmundo, F., Ravn Klausen, F., Mancinska, L., Steffan, V., Stilck Franca, D., Werner, A.
10.1101/2020.05.29.123612 — Posted: 2020-05-29
Rapid and Inexpensive Whole-Genome Sequencing of SARS-CoV2 using 1200 bp Tiled Amplicons and Oxford Nanopore Rapid Barcoding
Freed, N. E., Vlková, M., Faisal, M. B., Silander, O. K.
10.1101/2020.05.28.122648 — Posted: 2020-05-29
A simple Stochastic model for the SARS-CoV-2 Epidemic curve
Diogenes, A. N., Tedesco, D. G.
10.1101/2020.05.29.20116723 — Posted: 2020-05-29
SARS-CoV-2 SEROPREVALENCE AMONG ALL WORKERS IN A TEACHING HOSPITAL IN SPAIN: UNMASKING THE RISK.
Galan, I., Velasco, M., Casas, M. L., Goyanes, M. J., Rodriguez-Caravaca, G., Losa, J. E., Noguera, C., Castilla, V., Working Group Alcorcon COVID-19 investigators
10.1101/2020.05.29.20116731 — Posted: 2020-05-29
Duration of Viral Clearance in IDF Soldiers with Mild COVID-19
Talmy, T., Tsur, A., Shabtay, O.
10.1101/2020.05.28.20116145 — Posted: 2020-05-29
Novel indicators for evaluating topological threats to populations from pandemics applied to COVID-19
Adachi, S.
10.1101/2020.05.29.20116491 — Posted: 2020-05-29
Predicting the end-stage of the COVID-19 epidemic in Brazil
Webb, G. F., Fitzgibbon, W. E., Morgan, J. J., Wu, Y.
10.1101/2020.05.28.20116103 — Posted: 2020-05-29
Plasmin cascade mediates thrombolytic events in SARS-CoV-2 infection via complement and platelet-activating systems
Mukund, K., Mathee, K., Subramaniam, S.
10.1101/2020.05.28.120162 — Posted: 2020-05-29
Combining PCR and CT testing for COVID
Shen, C., Mark, R., Kagetsu, N. J., Becker, A. S., Bar-Yam, Y.
10.1101/2020.05.27.20114736 — Posted: 2020-05-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).